A case of inv(8)(p11q24) associated with acute myeloid leukemia involves the MOZ and CBP genes in a masked t(8;16)

Genes Chromosomes and Cancer

Volumn 26, Issue 2, 1999, Pages 161-165

  Chaffanet, Max ^a,b   Mozziconacci, Marie Joëlle ^b   Fernandez, Francisca ^b   Sainty, Danielle ^b   Lafage Pochitaloff, Marina ^a,b   Birnbaum, Daniel ^a,b   Pébusque, Marie Josèphe ^a  

^a INSERM   (France)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HYBRID PROTEIN; PROTEIN CBP; PROTEIN MOZ; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CHROMOSOME 16P; CHROMOSOME ABERRATION; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 8; CONTROLLED STUDY; FEMALE; FEVER; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; LYMPHADENOPATHY; PRIORITY JOURNAL; PROTEIN DOMAIN; SOUTHERN BLOTTING;

ACETYLTRANSFERASES; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 8; CREB-BINDING PROTEIN; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FEMALE; HISTONE ACETYLTRANSFERASES; HUMANS; INVERSION, CHROMOSOME; LEUKEMIA, MYELOCYTIC, ACUTE; MIDDLE AGED; NUCLEAR PROTEINS; TRANS-ACTIVATORS; TRANSLOCATION, GENETIC;

EID: 0032882205     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199910)26:2<161::AID-GCC8>3.0.CO;2-6     Document Type: Article

References (27)

1. Adélaïde J, Chaffanet M, Imbert A, Allione F, Geneix J, Popovici C, Van Alewijk D, Trapman J, Zeillinger R, Borresen-Dale A-L, Lidereau R, Birnbaum D, Pébusque M-J. 1998. Chromosome region 8p11-p21: refined mapping and molecular alterations in breast cancer. Genes Chromosomes Cancer 22:186-199.
2. Bannister AJ, Kouzarides T. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384:641-643.
3. Borrow J, Stanton VP Jr, Andressen JM, Becher R, Behm FG, Chaganti RSK, Civin CI, Disteche C, Dubé I, Frischauf AM, Hosman D, Mitelman F, Volinia S, Watmore AE, Housman DE. 1996. The translocation t(8;16)(p11;p13) of acute myeloid leukemia fuses a putative acetyl transferase to the CREB-binding protein. Nat Genet 14:33-41.
4. Carapeti M, Aguiar RCT, Goldman JM, Cross NCP. 1998. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. Blood 91:3127-3133.
5. Chaffanet M, Imbert A, Adélaïde J, Le Paslier D, Wagner MJ, Wells DE, Birnbaum D, Pébusque M-J. 1996. A 3.1 Mb YAC contig within the Werner syndrome region, on the short arm of chromosome 8. Cytogenet Cell Genet 72:63-68.
6. Chaffanet M, Popovici C, Leroux D, Jacrot M, Adélaïde J, Dastugue N, Grégoire M-J, Hagemeijer A, Lafage-Potchitaloff M, Birnbaum D, Pébusque M-J. 1998. t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12. Oncogene 16:945-949.
7. Coulthard S, Chase A, Orchard K, Watmore A, Vora A, Goldman JM, Swirsky DM. 1998. Two cases of inv(8)(p11q13) in AML with erythrophagocytosis: a new cytogenetic variant. Br J Haematol 100:561-563.
8. Fitzgerald P, Morris C. 1991. Complex chromosomal translocations in the Philadelphia chromosome leukemias: serial translocations or a concerted genomic rearrangement? Cancer Genet Cytogenet 57: 143-151.
9. Giles RH, Petrij F, Dauwerse HG, den Hollander AI, Lushnikova T, van Ommen G-JB, Goodman RH, Deaven LL, Doggett NA, Peters DJM, Breuning MH. 1997. Construction of a 1.2-Mb contig surrounding, and molecular analysis of the human CREB-binding protein (CBP/CREBBP) gene on chromosome 16p13.3. Genomics 42:96-114.
10. Giles RH, Peters DJM, Breuning MH. 1998. Conjunction dysfunction: CBP/p300 in human disease. Trends Genet 14:178-183.
11. Glass CK, Rose DW, Rosenfeld MG. 1997. Nuclear receptor coactivators. Current Opin Cell Biol 9:222-232.
12. 1 translocation? Cancer Genet Cytogenet 13:1-16.
13. Heim S, Avanzi GC, Billstrom R, Kristoffersson U, Mandahl N, Bekassy AN, Garwicz S, Wiebe T, Pegoraro L, Falda M, Resegotti L, Mitelman F. 1987. A new specific chromosomal rearrangement, t(8;16) (p11;p13), in acute monocytic leukaemia. Br J Haematol 66:323-326.
14. ISCN. 1995. An International System for Human Cytogenetic Nomenclature. In: Mitelman F, editor. Basel: Karger.
15. Lai JL, Zandecki M, Jouet JP, Savary JB, Lambiliotte A, Bauters F, Cosson A, Deminatti M. 1987. Three cases of translocation (8;16)(p11;p13) observed in acute myelomonocytic leukemia: a new specific subgroup? Cancer Genet Cytogenet 27:101-109.
16. Lai JL, Zandecki M, Fenaux P, Preudhomme C, Facon T, Deminatti M. 1992. Acute monocytic leukemia with (8;22)(p11;q13) translocation: involvement of 8p11 as in classical t(8;16)(p11;p13). Cancer Genet Cytogenet 60:180-182.
17. Liang J, Prouty L, Williams BJ, Dayton MA, Blanchard KL. 1998. Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2. Blood 92:2118-2122.
18. Macdonald D, Aguiar RC, Mason PJ, Goldman JM, Cross NC. 1995. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review. Leukemia 9:1628-1630.
19. Mitelman F, Heim S. 1992. Quantitative acute leukemia cytogenetics. Genes Chromosomes Cancer 5:57-66.
20. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959.
21. Popovici C, Adélaïde J, Ollendorff V, Chaffanet M, Guasch G, Jacrot M, Leroux D, Birnbaum D, Pébusque M-J. 1998. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)(p12;q12). Proc Natl Acad Sci USA 95:5712-5717.
22. Popovici C, Zhang B, Grégoire M-J, Jonveaux P, Lafage-Pochitaloff M, Birnbaum D, Pébusque M-J. 1999. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1. Blood 93:1381-1389.
23. Reiter A, Sohal J, Kulkarni S, Chase A, Macdonald DH, Aguiar RC, Goncalves C, Hernandez JM, Jennings BA, Goldman JM, Cross NC. 1998. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome. Blood 92:1735-1742.
24. Smedley D, Hamoudi R, Clark J, Warren W, Abdul-Rauf M, Somers G, Venter D, Fagan K, Cooper C, Shipley J. 1998. The t(8;13)(p11; q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP. Hum Mol Genet 7:637-642.
25. Stark B, Resnitzky P, Jeison M, Luria D, Blau O, Avigad S, Shaft D, Kodman Y, Gobuzov R, Ash S, Stein J, Yaniv I, Barak Y, Zaizov R. 1995. A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8;16)(p11;p13), in a patient with the variant t(8;19)(p11;q13): case report and review of the literature. Leuk Res 19:367-379.
26. Voegel JJ, Heine MJ, Tini M, Vivat V, Chambon P, Gronemeyer H. 1998. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J 17:507-519.
27. Xiao S, Nalabolu SR, Aster JC, Ma J, Abruzzo L, Jaffe ES, Stone R, Weissman SM, Hudson TJ, Fletcher JA. 1998. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nat Genet 18:84-87.